Recent Events & Catalysts
Genmab A/S (GMAB) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Genmab Stock Rises 4.4% as Drug Royalties Lift Outlook
Yahoo · 4d ago
Guggenheim Maintains Buy on Genmab, Raises Price Target to $42
Benzinga · 4d ago
Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript
SeekingAlpha · 4d ago
Genmab (GMAB) Q2 2026 Earnings Call Transcript
Yahoo · 4d ago
Genmab AS (GMAB) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Yahoo · 4d ago
Genmab A/S Q2 Earnings Call Highlights
Yahoo · 5d ago
Genmab shares jump 8% after upbeat results prompt 2026 outlook raise
Yahoo · 5d ago
Genmab Raises FY2026 Sales Guidance from $4.065B-$4.395B to $4.325B-$4.525B vs $4.355B Est
Benzinga · 5d ago
SEC Filings (90 days)
No 8-K filings in the last 90 days.
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.